Valuation Upgrade Commercial International Bank after CBE’s Interest Rate Hike

The Central Bank Decides to Raise the Interest Rate 6%

The monetary policy committee decided at its extraordinary meeting to raise the overnight deposit and lending rates and the main operation rate of the central bank by 600 basis points to reach 27.25%, 28.25% and 27.75%, respectively, and the credit and debit rate was raised by 600 basis points to reach 27.75%, and based on the decision taken by the committee at its meeting on the first of February 2024 to raise the basic interest rates by 200 basis points, the committee decided to accelerate the process of monetary restriction in order to accelerate the arrival of inflation on its downward path and ensure low monthly rates of inflation, the committee believes that the decision to raise the key interest rates by 600 basis points will help restrict monetary conditions in a manner consistent with the target path of reducing inflation rates. These levels will be maintained until inflation approaches its desired path, knowing that the central bank, despite raising interest during the first quarter of 2024 at a rate of 800 basis points, but has reduced interest during the past 2023 at a rate of 500 basis points. (Official statement of the Central Bank of Egypt)

 

Disclaimer

The contents of this report were prepared by Tycoon Research of Tycoon Securities Brokerage Company, for the purpose of knowledge and information, and this report cannot in any way be considered an incentive to make an investment decision. Information, estimates and analyzes contained in research reports or documents are as of the date published and are subject to change without notice. The information and opinions contained in the reports and documents have been compiled from reliable sources, but no representation or warranty is made, express or implied, as to their accuracy or reliability. Research reports and all opinions, conclusions and analyzes of the information contained therein are protected by copyright. Research reports or documents may not be republished or distributed, in whole or in part, without obtaining explicit approval from Tycoon Securities Brokerage. All research reports and documents are based on information of a general nature and represent the analyst's point of view, and Tycoon Research is not responsible for any decisions taken based on what is contained in the reports or research.

More like this

Egyptian International Pharmaceuticals-EIPICO (PHAR.CA)

Transitioning to Fully-Fledge Business Model Egyptian International Pharmaceuticals-EIPICO (PHAR.CA) is pursuing being a fully-fledged business model with the...